Adagene Inc. American Depositary Shares (ADAG)

Price$3.32

Value ScoreD

Growth ScoreA

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)57.25%

Price vs S&P 500 (4W)-10.02%

VGM Score66.79

Market Capitalization$169.64M

All Metrics

Book Value / Share (Quarterly)$0.88

P/TBV (Annual)0.76x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-6.18%

Cash Flow / Share (Quarterly)$-0.26

Price vs S&P 500 (YTD)67.50%

Net Profit Margin (TTM)-53.87%

EPS (TTM)$-0.30

10-Day Avg Trading Volume0.24M

EPS Excl Extra (TTM)$-0.30

Revenue Growth (5Y)61.42%

EPS (Annual)$-0.30

ROI (Annual)-30.35%

Net Profit Margin (5Y Avg)-6860.31%

Cash / Share (Quarterly)$1.26

Revenue Growth QoQ (YoY)7333.04%

ROA (Last FY)-22.50%

Revenue Growth TTM (YoY)7333.04%

EBITD / Share (TTM)$-0.36

ROE (5Y Avg)-53.98%

Operating Margin (TTM)-74.96%

Cash Flow / Share (Annual)$-0.26

P/B Ratio3.27x

P/B Ratio (Quarterly)1.65x

Net Income / Employee (Annual)$-137,600

EV / Revenue (TTM)13.20x

Net Interest Coverage (TTM)-79.31x

ROA (TTM)-24.33%

EPS Incl Extra (Annual)$-0.30

Current Ratio (Annual)3.07x

Quick Ratio (Quarterly)3.06x

3-Month Avg Trading Volume0.21M

52-Week Price Return88.64%

Revenue / Employee (TTM)$59,900

Tangible BV / Share (Quarterly)$1.92

P/S Ratio (Annual)22.11x

Asset Turnover (Annual)0.10x

52-Week High$4.75

Operating Margin (5Y Avg)-7372.27%

EPS Excl Extra (Annual)$-0.30

CapEx CAGR (5Y)-55.15%

26-Week Price Return65.17%

Quick Ratio (Annual)3.06x

13-Week Price Return9.93%

Total Debt / Equity (Annual)0.12x

Current Ratio (Quarterly)3.07x

Enterprise Value$101.23M

Revenue / Share Growth (5Y)52.04%

Asset Turnover (TTM)0.10x

Revenue / Employee (Annual)$59,900

Pretax Margin (Annual)-233.44%

Cash / Share (Annual)$1.26

3-Month Return Std Dev97.89%

Net Income / Employee (TTM)$-137,600

ROE (Last FY)-33.93%

EPS Basic Excl Extra (Annual)$-0.30

Receivables Turnover (TTM)6.20x

Total Debt / Equity (Quarterly)0.12x

EPS Incl Extra (TTM)$-0.30

Receivables Turnover (Annual)6.19x

ROI (TTM)-34.34%

P/S Ratio (TTM)22.11x

Pretax Margin (5Y Avg)-6858.29%

Revenue / Share (Annual)$0.13

Tangible BV / Share (Annual)$1.92

Price vs S&P 500 (52W)64.27%

Year-to-Date Return75.66%

5-Day Price Return-12.17%

EPS Normalized (Annual)$-0.30

ROA (5Y Avg)-33.48%

Net Profit Margin (Annual)-229.56%

Month-to-Date Return-16.37%

EBITD / Share (Annual)$-0.36

Operating Margin (Annual)-279.48%

LT Debt / Equity (Annual)0.02x

ROI (5Y Avg)-43.23%

LT Debt / Equity (Quarterly)0.02x

EPS Basic Excl Extra (TTM)$-0.30

P/TBV (Quarterly)0.76x

P/B Ratio (Annual)1.65x

Pretax Margin (TTM)-57.76%

Book Value / Share (Annual)$0.88

Price vs S&P 500 (13W)1.68%

Beta0.63x

Revenue / Share (TTM)$0.13

ROE (TTM)-39.21%

52-Week Low$1.30

vGradeD

gGradeA

mGradeB

vgmGradeB

Show chart for

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

4.15

4.17

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
ADAGAdagene Inc. American Depositary Shares	D	A	B	$3.32
LLYEli Lilly & Co.	D	B	B	$1131.42
JNJJohnson & Johnson	D	C	B	$232.77
ABBVABBVIE INC.	D	C	C	$227.23
MRKMerck & Co., Inc.	C	C	B	$120.79
NVSNovartis AG	C	C	C	$149.16
AZNAstraZeneca PLC	D	B	C	$185.95
NVONovo-Nordisk A/S	B	B	B	$42.96
ABTAbbott Laboratories	C	C	D	$91.07
PFEPfizer Inc.	B	C	C	$26.04
BMYBristol-Myers Squibb Co.	B	C	B	$57.27

About

Adagene is a clinical-stage biopharmaceutical company developing monoclonal antibody immunotherapies for cancer treatment. The company's proprietary platform generates therapeutic antibody candidates with enhanced functional epitopes and species cross-reactivity, enabling a differentiated pipeline of cancer immunotherapy programs.